Breaking Barriers in Biotech: COVID-19 and the Future of Biotech

9:15 AM - 10:00 AM (EDT), Monday, June 14, 2021
Search General Info
Search Education
Search Partnering Companies

The COVID-19 pandemic has changed the world in fundamental ways and the biotechnology sector has marshalled its broad arsenal of next-generation scientific advances to fight back against this disease.  As the world has undergone extraordinary transformation, BIO responded and transformed itself to address this new environment.  Journalist, television host and author, Brooke Baldwin, will moderate a conversation with BIO’s President and CEO, Dr. Michelle McMurry-Heath, BIO Chairman, Paul Hastings and BIO’s outgoing Chair, Dr. Jeremy Levin, as they discuss BIO’s priorities, progress on BIO’s 100 Days of Innovation, and what is to come for the biotech sector and our society. 



Author, Veteran Journalist, Former CNN Anchor
President & CEO
Nkarta Therapeutics, Inc.
Chairman of the Board of Directors and Chief Executive Officer
Ovid Therapeutics Inc.
President and CEO
Biotechnology Innovation Organization